2 exciting ETFs named as buys by experts

Here are two ETFs that could be buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here's what they are saying about them:

A young woman sits with her hand to her chin staring off to the side thinking about her investments.

Image source: Getty Images

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you're wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren't keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Exchange-Traded Funds (ETFs)

A laughing man standing next to a woman holds out his arm to a payments machine to pay with his smartwatch
Exchange-Traded Funds (ETFs)

3 strong ASX ETFs for smart investors to buy and hold

Looking to invest for the long-term? Here are three funds worth a closer look.

Read more »

ETF written in white on a multi coloured background.
Dividend Investing

Why I'd buy these 2 ASX ETFs for $10,000 a year in passive income

These two ASX ETFs provide a diversified means to earning a $10,000 yearly passive income.

Read more »

a man holds his hand to his chin with a furrowed brow, making an expression of puzzlement or confusion.
Exchange-Traded Funds (ETFs)

Too many ASX ETFs? You could be paying twice for the same shares

ETF overlap can mean higher fees and a false diversification illusion.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Exchange-Traded Funds (ETFs)

Down 21% in six weeks, what's happened to SEMI ETF?

SEMI invests in high-tech businesses, including semiconductor developers and manufacturers.

Read more »

Happy voter holding the US flag and a badge.
Exchange-Traded Funds (ETFs)

Why this NASDAQ-focused ASX ETF keeps outperforming

This fund provides simple high growth US diversification.

Read more »

ETF written in light blue on a chart.
Exchange-Traded Funds (ETFs)

3 strong Vanguard ETFs to buy with $3,000

One offers broad global exposure, another focuses on the US, and the third gives investors a way into Asia.

Read more »

two computer geeks sit across from each other with their laptop computers touching as they look confused and confounded by what they are seeing on their screens.
Exchange-Traded Funds (ETFs)

Australia finally has a quantum computing ETF. Should you invest?

A brand new theme, and a not-so-new set of risks.

Read more »

A heart next to a pink piggy bank and coins.
Exchange-Traded Funds (ETFs)

Why I would buy this safe ASX ETF with a 4% yield

There aren't many ETFs that offer a safe 4% yield and monthly payouts.

Read more »